z-logo
open-access-imgOpen Access
Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
Author(s) -
Christopher L. Edwards,
Renee Dunn Raynor,
Miriam Feliu,
Camela McDougald,
Stephanie Johnson,
Donald E. Schmechel,
Mary Wood,
Gary G. Bennett,
Patrick Saurona,
Melanie J. Bonner,
Laura DeCastro,
Mary Ann Abrams,
Patrick E. Logue,
Lekisha Edwards,
Salutario Martinez
Publication year - 2008
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s518
Subject(s) - neurocognitive , medicine , neuroimaging , neuropsychology , asymptomatic , disease , cognition , neuropsychological assessment , population , psychiatry , pediatrics , pathology , environmental health
Traditionally, neuropsychological deficits due to Sickle Cell Disease (SCD) have been understudied in adults. We have begun to suspect, however, that symptomatic and asymptomatic Cerebrovascular Events (CVE) may account for an alarming number of deficits in this population. In the current brief review, we critically evaluated the pediatric and adult literatures on the neurocognitive effects of SCD. We highlighted the studies that have been published on this topic and posit that early detection of CVE via neurocognitive testing, neuropsychiatric evaluations, and neuroimaging may significantly reduce adult cognitive and functional morbidities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom